We are live on ! Find out more
PYXS icon

Pyxis Oncology

78 hedge funds and large institutions have $40.5M invested in Pyxis Oncology in 2026 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 35 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,800% more call options, than puts

Call options by funds: $290K | Put options by funds: $10K

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

1% less funds holding

Funds holding: 79 → 78 (-1)

3.17% less ownership

Funds ownership: 48.5% → 45.33% (-3.2%)

21% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 14

48% less capital inflows, than outflows

Capital inflows: $2.54M | Capital outflows: $4.93M

66% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 35

Holders
78
Holders Change
-1
Holders Change %
-1.27%
% of All Funds
0.95%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.02%
New
11
Increased
12
Reduced
35
Closed
14
Calls
$290​K
Puts
$10​K
Net Calls
+$280​K
Net Calls Change
-⁠$218​K

PYXS Hedge Fund Activity: Q1 2026 in Review

78 of the 8,241 institutional investors tracked by Wall St. Rank reported a position in Pyxis Oncology (PYXS) for Q1 2026, worth a combined $40.5M — up 17% from $34.7M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of PYXS and 11 opened new positions — a net loss of 3 holders — while 35 trimmed existing stakes and 12 added.

The largest buyer was HealthInvest Partners, adding an estimated $740K. The largest seller was Bank of America, cutting an estimated $861K.

  • 78 institutional investors held Pyxis Oncology (PYXS) as of Q1 2026, down from 79 in Q4 2025.
  • Funds reported $40.5M of Pyxis Oncology stock for Q1 2026, up 17% quarter-over-quarter.
  • 11 funds opened new Pyxis Oncology positions in Q1 2026 and 14 closed out, a net change of -3 holders.
  • The largest Pyxis Oncology buyer in Q1 2026 was HealthInvest Partners, an estimated $740K added.
  • The largest Pyxis Oncology seller in Q1 2026 was Bank of America, an estimated $861K sold.

Based on aggregated 13F filings for Q1 2026.